We have located links that may give you full text access.
English Abstract
Journal Article
[An effectiveness of surfactant lung lavage (SLL) in meconium aspiration syndrome (MAS)].
Przegla̧d Lekarski 2002
UNLABELLED: The aim of our study was to evaluate an effect of surfactant lung lavage (SLL) in severe meconium aspiration syndrome (MAS).
MATERIAL: 22 neonates were divided into 2 groups: group A treated with SLL (n = 11) and group B--historic control (n = 11). The criteria for entry into the study were as follows: stain amniotic fluid, meconium below vocal cords, gestational age > 35 wks, time after delivery < 6 h, clinical manifestation of severe respiratory insufficiency, need for mechanical ventilation (FiO2 > 0.4) and pathological chest X-ray.
METHOD: SLL was done between 1. and 6. hours of life with natural surfactant (Survanta) in concentration 5 mg of phospholipids/1 ml 0.9% NaCl (15 ml of solution per kg). Following data were analyzed IO, PaO2, FiO2 (before treatment and 1, 2, 4, 48 hours after), duration of hospitalization, death rate.
RESULTS: The mean value in group A (+/- SD) before SLL were as follow: IO 19.0 (12.4). PaO2--51.4 mmHg (14.1). FiO2--0.8 (0.3); after 1 hour: IO--13.7 (9.4). PaO2--63.8 mmHg (16.8). FiO2--0.7 (0.3). After 48 hours: IO--4.2 (2.4). PaO2--60.5 mmHg (7.2). FiO2--0.38 (0.1); duration of IMV--5.6 days (4.1); duration of hospitalization--20.5 days (8.8). No deaths occurred. In group B in 1st hour of life mean value (+/- SD) were as follows: IO 22.4 (14.5). PaO2--47.7 mmHg (12.1). FiO2--0.8 (10.3); after 1 hour: IO--21.5 (17.8). PaO2--52.2 mmHg (24.1). FiO2--0.7 (0.3); after 48 hours: IO--7.6 (5.8). PaO2--57.7 (16.4) mmHg. FiO2--0.5 (0.3); duration of IMV--5.9 days (4.8); duration of hospitalization--22.4 days (11.3). One newborn died in group B.
CONCLUSION: Our pilot SLL study showed the benefit of this procedure in newborns with severe MAS. In treating MAS, SLL allows to achieve lower IO and higher of PaO2 after 1 hour, shorten the time of mechanical ventilation and hospitalization.
MATERIAL: 22 neonates were divided into 2 groups: group A treated with SLL (n = 11) and group B--historic control (n = 11). The criteria for entry into the study were as follows: stain amniotic fluid, meconium below vocal cords, gestational age > 35 wks, time after delivery < 6 h, clinical manifestation of severe respiratory insufficiency, need for mechanical ventilation (FiO2 > 0.4) and pathological chest X-ray.
METHOD: SLL was done between 1. and 6. hours of life with natural surfactant (Survanta) in concentration 5 mg of phospholipids/1 ml 0.9% NaCl (15 ml of solution per kg). Following data were analyzed IO, PaO2, FiO2 (before treatment and 1, 2, 4, 48 hours after), duration of hospitalization, death rate.
RESULTS: The mean value in group A (+/- SD) before SLL were as follow: IO 19.0 (12.4). PaO2--51.4 mmHg (14.1). FiO2--0.8 (0.3); after 1 hour: IO--13.7 (9.4). PaO2--63.8 mmHg (16.8). FiO2--0.7 (0.3). After 48 hours: IO--4.2 (2.4). PaO2--60.5 mmHg (7.2). FiO2--0.38 (0.1); duration of IMV--5.6 days (4.1); duration of hospitalization--20.5 days (8.8). No deaths occurred. In group B in 1st hour of life mean value (+/- SD) were as follows: IO 22.4 (14.5). PaO2--47.7 mmHg (12.1). FiO2--0.8 (10.3); after 1 hour: IO--21.5 (17.8). PaO2--52.2 mmHg (24.1). FiO2--0.7 (0.3); after 48 hours: IO--7.6 (5.8). PaO2--57.7 (16.4) mmHg. FiO2--0.5 (0.3); duration of IMV--5.9 days (4.8); duration of hospitalization--22.4 days (11.3). One newborn died in group B.
CONCLUSION: Our pilot SLL study showed the benefit of this procedure in newborns with severe MAS. In treating MAS, SLL allows to achieve lower IO and higher of PaO2 after 1 hour, shorten the time of mechanical ventilation and hospitalization.
Full text links
Related Resources
Trending Papers
Consensus Statement on Vitamin D Status Assessment and Supplementation: Whys, Whens, and Hows.Endocrine Reviews 2024 April 28
The Tricuspid Valve: A Review of Pathology, Imaging, and Current Treatment Options: A Scientific Statement From the American Heart Association.Circulation 2024 April 26
Intravenous infusion of dexmedetomidine during the surgery to prevent postoperative delirium and postoperative cognitive dysfunction undergoing non-cardiac surgery: a meta-analysis of randomized controlled trials.European Journal of Medical Research 2024 April 19
Interstitial Lung Disease: A Review.JAMA 2024 April 23
Management of Diverticulitis: A Review.JAMA Surgery 2024 April 18
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app